Eurofins to buy diagnostic PCR specialist for $50m

By Gareth Macdonald contact

- Last updated on GMT

PCR goes made, or at least is increasingly popular among drug firms: Eurofins to buy Diatherix
PCR goes made, or at least is increasingly popular among drug firms: Eurofins to buy Diatherix

Related tags: Health care provider, Pharmacology

Eurofins Scientific has agreed to buy diagnostic testing services firm Diatherix Laboratories for $50m (EUR55m).

The deal, which is expected to complete this month, will bring with it Diatherix’ capabilities in DNA and RNA testing, which are used by 7,000 healthcare professionals for diagnostics and sample analysis.

Eurofins CEO Gilles Martin said: “Diatherix strengthens Eurofins’ growing footprint in the specialty clinical diagnostics market, with truly unique and innovative services with high positive impact for patient care.

Biopharma focus

News of the deal comes just over a year after Eurofins bought ViraCor-IBT Laboratories, a specialist in biomarker analysis for hospitals and biopharmaceutical companies and is part of the same expansion strategy according to Martin.

This acquisition reflects our strategy of expanding and strengthening our network of competence centers. In combination with ViraCor and Boston Heart, Diatherix reinforces the Group’s position in genetic testing to better serve the global healthcare community​.”

It also follows two months after Eurofins' bioanalytical services arm launched an immunoassay service​ for biopharma developers.

Pall​ and Selvita​ have also recently invested in their bioassay platforms for large molecule drug development services.  

Bio-outsourcing is on the rise, reports show,​ with analytical testing – such as assays – topping the list of tasks pharma companies and healthcare providers are willing to send out of house.

Related news

Show more

Related products

show more

How clinical trial software can optimize trials

How clinical trial software can optimize trials

Formedix | 20-Jun-2022 | Technical / White Paper

This article explains the different types of clinical trial software available, and how it can be used to optimize the end to end clinical trials design...

Strategic Approach to Immunogenicity Assessment

Strategic Approach to Immunogenicity Assessment

Altasciences | 17-May-2022 | Technical / White Paper

In this issue of The Altascientist we provide a detailed overview on the different goals and challenges that are presented by the validation of immunogenicity...

Governing and Maintaining Clinical Data Standards

Governing and Maintaining Clinical Data Standards

Veeva | 10-May-2022 | Technical / White Paper

Investing in data standards plays a huge role in improving the quality of clinical studies. But often, people don’t use the standards correctly, there...

What the Best Clinical Study Build Pros Do

What the Best Clinical Study Build Pros Do

Formedix | 09-May-2022 | Technical / White Paper

Getting your clinical study designed and built ready for data collection takes A LOT of work and expertise… you've got to do all your CRF designs;...

Related suppliers

Follow us

Products

View more

Webinars